BALANCE SHEET
AstraZeneca Pharma India Ltd.
BSE
Jun 19, 04:01
9422.95
-311.70 ( -3.20%)
Volume
4381
Prev. Close
9734.65
Open Price
9599.85
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 19, 03:59
9410.50
-324.00 ( -3.33%)
Volume
40260
Prev. Close
9734.50
Open Price
9680.50
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
9410.50 (55)
You can view the
Balance Sheet
for the last 5 years.
ISIN No
|
INE203A01020
|
Market Cap. ( ₹ in Cr. )
|
23526.25
|
P/BV
|
34.63
|
Book Value ( ₹ )
|
271.74
|
BSE Code
|
506820
|
52 Week High/Low ( ₹ )
|
10691/6070
|
FV/ML
|
2/1
|
P/E(X)
|
203.27
|
NSE Code
|
ASTRAZENEQ
|
Book Closure
|
05/07/2024
|
EPS ( ₹ )
|
46.30
|
Div Yield (%)
|
0.34
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
No. of Equity Shares (in Lacs) | 250.00 | 250.00 | 250.00 | 250.00 | 250.00 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Total Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | |
Reserves and Surplus | 765.35 | 706.92 | 583.69 | 506.39 | 451.17 |
Total Reserves and Surplus | 765.35 | 706.92 | 583.69 | 506.39 | 451.17 |
Total Shareholders Funds | 770.35 | 711.92 | 588.69 | 511.39 | 456.17 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Other Long Term Liabilities | 38.45 | 2.78 | 3.69 | 5.02 | 8.63 |
Long Term Provisions | 6.32 | 6.21 | 8.56 | 7.50 | 6.41 |
Total Non-Current Liabilities | 44.77 | 8.99 | 12.25 | 12.52 | 15.04 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Trade Payables | 456.30 | 196.51 | 227.88 | 188.06 | 178.37 |
Other Current Liabilities | 140.17 | 117.19 | 114.37 | 104.42 | 88.21 |
Short Term Provisions | 106.53 | 43.42 | 41.68 | 40.17 | 36.92 |
Total Current Liabilities | 703.00 | 357.12 | 383.93 | 332.65 | 303.50 |
| | | | | |
Total Capital And Liabilities | 1518.12 | 1078.03 | 984.87 | 856.56 | 774.71 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 63.58 | 64.57 | 68.86 | 74.49 | 80.96 |
Intangible Assets | 0.66 | 2.11 | 0.00 | 0.00 | 0.00 |
Capital Work-In-Progress | 0.00 | 0.27 | 1.33 | 2.20 | 4.02 |
Fixed Assets | 64.24 | 66.95 | 70.19 | 76.69 | 84.98 |
Deferred Tax Assets [Net] | 41.56 | 21.25 | 20.67 | 16.30 | 14.53 |
Long Term Loans And Advances | 0.11 | 0.27 | 0.88 | 0.41 | 4.33 |
Other Non-Current Assets | 69.86 | 56.85 | 57.66 | 57.49 | 52.11 |
Total Non-Current Assets | 175.77 | 145.32 | 149.40 | 150.89 | 155.95 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Inventories | 548.50 | 227.88 | 190.21 | 140.22 | 159.80 |
Trade Receivables | 184.88 | 153.13 | 107.52 | 85.89 | 85.19 |
Cash And Cash Equivalents | 536.70 | 505.84 | 500.48 | 448.46 | 352.35 |
Short Term Loans And Advances | 0.30 | 0.13 | 0.08 | 0.09 | 0.36 |
OtherCurrentAssets | 71.97 | 45.73 | 37.18 | 31.01 | 21.06 |
Total Current Assets | 1342.35 | 932.71 | 835.47 | 705.67 | 618.76 |
| | | | | |
Total Assets | 1518.12 | 1078.03 | 984.87 | 856.56 | 774.71 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 0.00 | 138.25 | 132.28 | 124.60 | 89.17 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 0.00 | 2.50 | 2.50 | 2.50 | 2.50 |